Clinical Edge Journal Scan

Risk for hospitalized infections reduces with improved disease activity in moderate RA


 

Key clinical point: Patients with rheumatoid arthritis (RA) and low or moderate disease activity were at a higher risk for hospitalized infections compared with those in remission.

Major finding: Compared with patients attaining remission, patients attaining low disease activity (adjusted hazard ratio [aHR] 1.60; 95% CI 1.13-2.27) and moderate disease activity (aHR 1.83; 95% CI 1.29-2.61) were at a higher risk for hospitalized infections.

Study details: Findings are from a prospective observational cohort study including 3254 patients with moderate RA from the CorEvitas RA registry.

Disclosures: H Yun and JR Curtis declared receiving support from US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases. Two authors reported being employees and shareholders of CorEvitas LLC. Several authors reported receiving research funding from or serving on speakers bureaus or as consultants for various sources.

Source: Yun H et al. Rheumatoid arthritis disease activity and hospitalized infection in a large U.S. registry. Arthritis Care Res (Hoboken). 2022 (Jul 22). Doi: 10.1002/acr.24984

Recommended Reading

FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
MDedge Rheumatology
Early methotrexate does not prevent progression to arthritis in arthralgia patients at risk for RA
MDedge Rheumatology
TNFi use during pregnancy in women with RA increases birth weight of offspring
MDedge Rheumatology
Risk for herpes zoster with first-line b/tsDMARD in seropositive RA in real world
MDedge Rheumatology
RA: Stopping bDMARD early in pregnancy increases risk for disease flare and preterm delivery
MDedge Rheumatology
Meta-analysis evaluates safety and efficacy of JAKi in RA
MDedge Rheumatology
Increased risk for dementia among patients with clinically active RA
MDedge Rheumatology
Presence of anti-SSA antibody reduces response to conventional RA treatment
MDedge Rheumatology
Serum fatty acid profile tied to disease activity in early RA
MDedge Rheumatology
Sulfonylureas or biguanides reduce risk for RA in patients with diabetes
MDedge Rheumatology